Posts
March 09 2017
Kayne Anderson Capital Advisors LP announced their plans for an initial public offering that would raise $350 million for a special purpose acquisition company, or “blank-check company,” with its sights on acquiring an energy business. EG&S is counsel to Kayne.
March 02 2017
James K. Landau, a member of the Firm, was invited by PLI to participate on a panel discussing the use of social media by attorneys on March 17, 2017.
Click here for more details
February 27 2017
Daseke, Inc. and Hennessy Capital Acquisition Corp. II announced the completion of their business combination. EG&S acted as special SPAC counsel to Hennessy.
February 24 2017
Arch Therapeutics Inc. announced the closing of their Registered Direct offering in the amount of $6,100,000. EG&S acted as counsel to the lead Investor.
February 23 2017
Biopharmaceuticals Ltd. announced the closing of their Registered Direct offering in the amount of $2,500,000. EG&S acted as counsel to the Placement Agent.
February 21 2017
Ellenoff Grossman & Schole LLP is proud to announce the addition of a new practice group – Immigration. John Assadi joins EG&S as a Member and Mauricio Martinez as an Associate.
Click here to view the announcement
February 15 2017
Biostage, Inc. announced the closing of their Registered Direct offering in the amount of $8,000,000. EG&S acted as counsel to the Placement Agent.
February 14 2017
Moleculin Biotech, Inc. announced the closing of their Underwritten offering in the amount of $4,657,905. EG&S acted as counsel to the Underwriter.